0001209191-17-042901.txt : 20170703 0001209191-17-042901.hdr.sgml : 20170703 20170703192040 ACCESSION NUMBER: 0001209191-17-042901 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170515 FILED AS OF DATE: 20170703 DATE AS OF CHANGE: 20170703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMARIN CORP PLC\UK CENTRAL INDEX KEY: 0000897448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: FIRST FLOOR, BLOCK 3, THE OVAL, STREET 2: SHELBOURNE ROAD, BALLSBRIDGE CITY: DUBLIN STATE: L2 ZIP: 00000 BUSINESS PHONE: 353 1 6699 020 MAIL ADDRESS: STREET 1: FIRST FLOOR, BLOCK 3, THE OVAL, STREET 2: SHELBOURNE ROAD, BALLSBRIDGE CITY: DUBLIN STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC DATE OF NAME CHANGE: 20000201 FORMER COMPANY: FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC DATE OF NAME CHANGE: 19930322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kennedy Joseph T CENTRAL INDEX KEY: 0001408920 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21392 FILM NUMBER: 17945988 MAIL ADDRESS: STREET 1: C/O TRANSCEPT PHARMACEUTICALS, INC. STREET 2: 1003 W. CUTTING BLVD., SUITE 110 CITY: POINT RICHMOND STATE: CA ZIP: 94804 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-15 0 0000897448 AMARIN CORP PLC\UK AMRN 0001408920 Kennedy Joseph T C/O AMARIN PHARMA, INC. 1430 ROUTE 206 BEDMINSTER NJ 07921 0 1 0 0 General Counsel Ordinary Shares 2017-06-29 4 S 0 151768 3.9786 D 130591 D Ordinary Shares 2017-06-30 4 M 0 47187 A 177778 D Ordinary Shares 2017-06-30 4 M 0 6250 A 184028 D Ordinary Shares 2017-06-30 4 F 0 27885 4.03 D 156143 D Ordinary Shares 2017-06-30 4 S 0 105039 3.979 D 51104 D Ordinary Shares 2017-07-03 4 S 0 51104 4.0928 D 0 D Restricted Stock Units 0.00 2017-05-15 4 A 0 108000 0.00 A Ordinary Shares 108000 108000 D Restricted Stock Units 0.00 2017-06-30 4 M 0 47187 0.00 D Ordinary Shares 47187 377500 D Restricted Stock Units 0.00 2017-06-30 4 M 0 6250 0.00 D Ordinary Shares 6250 50000 D The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. Sales made pursuant to a 10b5-1 trading plan dated November 7, 2016. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.96 to $4.07, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of Ordinary Shares sold at each separate price. Please see the section titled "Remarks" below for additional information. As previously reported on July 8, 2015, the Reporting Person was granted 755,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in 16 equal quarterly installments. The eighth vesting event occurred on June 30, 2017. Not applicable. As previously reported on October 6, 2015, the Reporting Person was granted 100,000 RSUs under the Plan. These RSUs vest in 16 equal quarterly installments. The eighth vesting event occurred on June 30, 2017. Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.96 to $4.03, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of Ordinary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.05 to $4.14, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of Ordinary Shares sold at each separate price. Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. On February 1, 2017, the Reporting Person was granted 108,000 RSUs under the Plan. These RSUs were subject to the approval by the Company's shareholders of an amendment to the Plan, which amendment was approved on May 15, 2017, and were previously disclosed in the Company's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 21, 2017. These RSUs vest in three equal installments on each of January 31, 2018, January 31, 2019 and January 31, 2020. In the event of a Change of Control (as defined in the Plan), the grants described in this Form 4 vest in full. As of the date of this Form 4, the Reporting Person owns or holds the right to acquire an aggregate of 3,491,270 Ordinary Shares of the Issuer in the form of stock options and Restricted Stock Units granted under the Amarin Corporation plc 2002 Stock Option Plan and the Plan. /s/ Joseph T. Kennedy 2017-07-03